サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1784049

予防ヘルスケア技術とサービスの世界市場

Preventive Healthcare Technologies and Services

出版日
ページ情報
英文 185 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.26円
予防ヘルスケア技術とサービスの世界市場
出版日: 2025年08月05日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 185 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

予防ヘルスケア技術とサービスの世界市場は2030年までに5億2,110万米ドルに達する見込み

2024年に2億9,790万米ドルと推定される予防ヘルスケア技術とサービスの世界市場は、2024年から2030年にかけてCAGR 9.8%で成長し、2030年には5億2,110万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである早期発見・スクリーニング技術は、CAGR 8.8%を記録し、分析期間終了時には1億9,970万米ドルに達すると予測されます。慢性疾患管理技術分野の成長率は、分析期間中CAGR 8.9％と推定されます。

米国市場は8,120万米ドルと推定、中国はCAGR13.2％で成長予測

米国の予防ヘルスケア技術とサービス市場は、2024年に8,120万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに1億520万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは13.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.1%と8.5%と予測されています。欧州では、ドイツがCAGR 7.6%で成長すると予測されています。

世界の予防ヘルスケア技術とサービス市場- 主要動向と促進要因まとめ

なぜ予防ヘルスケアは世界の医療業界で勢いを増しているのか？

予防ヘルスケア技術とサービスは、ヘルスケアシステムが疾病負担を軽減し、患者の転帰を改善し、医療費を削減するための予防的対策にシフトするにつれ、大きな成長を遂げています。病気の治療に重点を置く消極的なヘルスケアモデルとは異なり、予防的ヘルスケアは、糖尿病、心血管疾患、がんなどの慢性疾患を予防するために、早期診断、リスク評価、生活習慣の改善を重視します。生活習慣病がますます蔓延する中、政府、保険会社、ヘルスケア・プロバイダーは、予防接種プログラム、早期スクリーニング・ツール、個別化された健康モニタリング・ソリューションなどの予防戦略を優先しています。デジタルヘルスプラットフォーム、ウェアラブルデバイス、人工知能主導型診断の台頭は、予防医療へのアクセス性と精度をさらに高めています。また、消費者の健康意識も高まり、ウェルネスを重視した行動を取り、テクノロジーを活用して健康状態を追跡・管理するようになっています。官民のヘルスケア部門が予防対策への投資を続ける中、予防ヘルスケア技術とサービスの世界市場は拡大し、ヘルスケア提供の未来を再構築することになるでしょう。

予防ヘルスケアの成長を妨げる課題とは？

その利点にもかかわらず、予防ヘルスケア技術の普及は複数の課題に直面しています。主な障壁のひとつは、先進的な診断ツールや健康診断サービスにかかる費用であり、特に低所得者層では、すべての人々にとって手の届く金額ではないかもしれないです。予防ヘルスケアに対する標準的な政策や償還構造がないため、保険プロバイダーは予防よりも治療を優先することが多く、予防ヘルスケアへのアクセスがさらに制限されます。さらに、多くの患者が検診を遅らせたり、初期症状を無視したり、定期的な健康診断を受けなかったりするため、患者の予防ヘルスケア対策へのアドヒアランスが依然として懸念されています。また、電子カルテ（EHR）、デジタルヘルス機器、AI主導のアナリティクス間の相互運用性の問題に対処しなければならないため、複数のプラットフォーム間で予防ヘルスケアデータを統合することの複雑さも、医療提供者に課題を突きつけています。さらに、ワクチン、予防薬、デジタルヘルスモニタリングを取り巻く誤った情報や懐疑的な見方が、市場への浸透を遅らせる可能性もあります。こうした課題に対処するには、政府の支援強化、国民の意識向上キャンペーン、テクノロジープロバイダーとヘルスケア機関の戦略的連携が必要です。

技術の進歩は予防ヘルスケアをどのように強化するのか？

技術革新は予防ヘルスケア革命の最前線にあり、より正確で効率的、かつ個別化された健康介入を可能にしています。人工知能とビッグデータ解析の統合により、疾病予測モデルが改善され、ヘルスケア専門家が高リスク者を特定し、早期介入戦略を実施できるようになっています。ウェアラブル・ヘルス・トラッカーやスマート医療機器によって、消費者は心拍数、血圧、グルコース・レベルなどの主要な健康指標をモニターできるようになり、予防医療のためのリアルタイム・フィードバックが提供されるようになっています。遠隔医療とデジタル・ヘルス・プラットフォームは、遠隔診察、デジタル・ヘルス・コーチング、AI主導の診断を促進することで、予防サービスへのアクセスをさらに拡大しています。ゲノム医療と予測バイオマーカー分析は、遺伝的素因を特定することで個別化ヘルスケアに革命をもたらし、オーダーメイドの予防戦略を可能にしています。さらに、ブロックチェーン技術が安全な医療データ共有のために検討されており、データ主導型の予防ヘルスケアソリューションを改善しながら患者のプライバシーを確保しています。これらのテクノロジーが進化を続けるにつれて、予防ヘルスケアはより効果的でコスト効率に優れ、世界中の人々が広く利用できるようになると思われます。

予防ヘルスケア技術とサービス市場の成長の原動力は？

予防ヘルスケア技術とサービス市場の成長は、慢性疾患予防に対する意識の高まり、診断技術の進歩、デジタルヘルスソリューションの拡大など、いくつかの要因によってもたらされます。ウェアラブルヘルス技術やAIを活用した予測分析の採用が増加しており、個別化された予防医療の需要が加速しています。疾病の早期発見やワクチン接種プログラムを推進する政府の政策が、特に医療インフラが整備された先進地域での市場拡大をさらに後押ししています。企業部門も成長に貢献しており、雇用主は従業員の健康と生産性を高めるためにウェルネス・プログラムや予防検診に投資しています。さらに、予防医療戦略に遠隔医療サービスが統合されることで、特に遠隔地で十分なサービスを受けていない人々にとってのアクセシビリティが向上しています。ヘルスケア提供者、保険者、消費者が予防医療の長期的なメリットを認識し続けているため、この市場は持続的な成長を遂げ、世界的に健康とウェルネスの管理方法を変革していくと予想されます。

セグメント

タイプ別（早期発見・スクリーニング技術、慢性疾患管理技術、ワクチン、その他のタイプ）

調査対象企業の例

  • Abbott Laboratories
  • Cerner Corporation
  • Cigna
  • Epic Systems Corporation
  • GlaxoSmithKline plc（GSK）
  • Health Catalyst
  • IBM Watson Health
  • Johnson & Johnson
  • McKesson Corporation
  • Medtronic plc
  • Merck & Co., Inc.
  • Myriad Genetics
  • NovX Systems Corp.
  • Omron Healthcare, Inc.
  • Pfizer Inc.
  • Quest Diagnostics
  • Sanofi
  • Siemens Healthineers
  • Teladoc Health
  • UnitedHealth Group

AIインテグレーションズ

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP32689

Global Preventive Healthcare Technologies and Services Market to Reach US$521.1 Million by 2030

The global market for Preventive Healthcare Technologies and Services estimated at US$297.9 Million in the year 2024, is expected to reach US$521.1 Million by 2030, growing at a CAGR of 9.8% over the analysis period 2024-2030. Early Detection & Screening Technologies, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$199.7 Million by the end of the analysis period. Growth in the Chronic Disease Management Technologies segment is estimated at 8.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$81.2 Million While China is Forecast to Grow at 13.2% CAGR

The Preventive Healthcare Technologies and Services market in the U.S. is estimated at US$81.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$105.2 Million by the year 2030 trailing a CAGR of 13.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.1% and 8.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.6% CAGR.

Global Preventive Healthcare Technologies and Services Market - Key Trends & Drivers Summarized

Why Is Preventive Healthcare Gaining Momentum in the Global Medical Industry?

Preventive healthcare technologies and services have witnessed substantial growth as healthcare systems shift toward proactive measures to reduce disease burden, improve patient outcomes, and lower medical costs. Unlike reactive healthcare models that focus on treating illnesses, preventive healthcare emphasizes early diagnosis, risk assessment, and lifestyle modifications to prevent chronic diseases such as diabetes, cardiovascular disorders, and cancer. With the increasing prevalence of lifestyle-related diseases, governments, insurers, and healthcare providers are prioritizing preventive strategies, including vaccination programs, early screening tools, and personalized health monitoring solutions. The rise of digital health platforms, wearable devices, and artificial intelligence-driven diagnostics has further enhanced the accessibility and accuracy of preventive healthcare. Consumers are also becoming more health-conscious, adopting wellness-focused behaviors and leveraging technology to track and manage their health. As public and private healthcare sectors continue investing in preventive measures, the global market for preventive healthcare technologies and services is set to expand, reshaping the future of healthcare delivery.

What Challenges Are Hindering the Growth of Preventive Healthcare?

Despite its advantages, the widespread adoption of preventive healthcare technologies faces multiple challenges. One of the primary barriers is the cost of advanced diagnostic tools and health screening services, which may not be affordable for all populations, particularly in low-income regions. The lack of standardized policies and reimbursement structures for preventive healthcare further limits its accessibility, as insurance providers often prioritize treatment over prevention. Additionally, patient adherence to preventive healthcare measures remains a concern, as many individuals delay screenings, ignore early symptoms, or fail to maintain regular health check-ups. The complexity of integrating preventive healthcare data across multiple platforms also presents challenges for healthcare providers, as interoperability issues between electronic health records (EHRs), digital health devices, and AI-driven analytics must be addressed. Moreover, misinformation and skepticism surrounding vaccines, preventive medications, and digital health monitoring can slow market penetration. Addressing these challenges requires increased government support, public awareness campaigns, and strategic collaborations between technology providers and healthcare institutions.

How Are Technological Advancements Enhancing Preventive Healthcare?

Technological innovation is at the forefront of the preventive healthcare revolution, enabling more precise, efficient, and personalized health interventions. The integration of artificial intelligence and big data analytics is improving disease prediction models, allowing healthcare professionals to identify high-risk individuals and implement early intervention strategies. Wearable health trackers and smart medical devices are empowering consumers to monitor key health metrics such as heart rate, blood pressure, and glucose levels, providing real-time feedback for preventive care. Telemedicine and digital health platforms are further expanding access to preventive services by facilitating remote consultations, digital health coaching, and AI-driven diagnostics. Genomic medicine and predictive biomarker analysis are revolutionizing personalized healthcare by identifying genetic predispositions to diseases, enabling tailored prevention strategies. Additionally, blockchain technology is being explored for secure health data sharing, ensuring patient privacy while improving data-driven preventive healthcare solutions. As these technologies continue to evolve, preventive healthcare will become more effective, cost-efficient, and widely accessible across global populations.

What Is Driving the Growth of the Preventive Healthcare Technologies and Services Market?

The growth in the preventive healthcare technologies and services market is driven by several factors, including increasing awareness of chronic disease prevention, advancements in diagnostic technologies, and the expansion of digital health solutions. The rising adoption of wearable health technology and AI-powered predictive analytics is accelerating the demand for personalized preventive care. Government policies promoting early disease detection and vaccination programs are further supporting market expansion, particularly in developed regions with strong healthcare infrastructure. The corporate sector is also contributing to growth, with employers investing in wellness programs and preventive screenings to enhance workforce health and productivity. Additionally, the integration of telehealth services into preventive care strategies is improving accessibility, particularly for remote and underserved populations. As healthcare providers, insurers, and consumers continue to recognize the long-term benefits of preventive healthcare, the market is expected to witness sustained growth, transforming the way health and wellness are managed globally.

SCOPE OF STUDY:

The report analyzes the Preventive Healthcare Technologies and Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines, Other Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories
  • Cerner Corporation
  • Cigna
  • Epic Systems Corporation
  • GlaxoSmithKline plc (GSK)
  • Health Catalyst
  • IBM Watson Health
  • Johnson & Johnson
  • McKesson Corporation
  • Medtronic plc
  • Merck & Co., Inc.
  • Myriad Genetics
  • NovX Systems Corp.
  • Omron Healthcare, Inc.
  • Pfizer Inc.
  • Quest Diagnostics
  • Sanofi
  • Siemens Healthineers
  • Teladoc Health
  • UnitedHealth Group

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Preventive Healthcare Technologies and Services - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Chronic Diseases Throws the Spotlight on Proactive Risk Mitigation and Health Monitoring
    • Expansion of Digital Health Ecosystems Drives Adoption of Remote Preventive Screening and Health Management Services
    • Integration of AI and Predictive Analytics in Early Detection Platforms Strengthens Business Case for Risk-Based Interventions
    • Growth in Wearable Devices and Mobile Health Apps Spurs Continuous Personal Health Data Collection and Monitoring
    • Government-Led Public Health Campaigns and Incentives Propel Mass Adoption of Preventive Care Solutions
    • Rising Consumer Awareness Around Preventive Health and Wellness Drives Demand for Personalized Diagnostic Services
    • Increasing Penetration of Telemedicine and Virtual Consultations Expands Access to Preventive Health Technologies
    • Development of Integrated Health Information Platforms Accelerates Interoperability and Coordinated Preventive Care
    • Focus on Value-Based Healthcare Models Drives Investments in Preventive Rather Than Reactive Treatment Approaches
    • Emergence of At-Home Testing Kits and Point-of-Care Devices Generates Demand for Decentralized Screening Programs
    • Adoption of Population Health Management Platforms Expands Addressable Market for Enterprise-Scale Preventive Solutions
    • Shift Toward Genomic and Epigenetic Risk Profiling Spurs Growth in Predictive Preventive Diagnostics
    • Increased Emphasis on Immunization and Vaccine Management Strengthens Role of Preventive Services in Public Health
    • Expansion of Corporate Wellness Programs and Employee Health Benefits Drives Organizational Investments in Preventive Care
    • Growth in AI-Powered Chatbots and Virtual Coaches Enhances Patient Engagement in Preventive Health Routines
    • Regulatory Push for Preventive Screening Guidelines and Early Detection Protocols Drives Clinical Implementation
    • Integration of Behavioral and Mental Health Modules into Preventive Platforms Spurs Holistic Health Management
    • Increased Use of Cloud-Based Analytics Enhances Risk Prediction Models and Personalized Preventive Treatment Plans
    • Partnerships Between Tech Firms and Healthcare Providers Propel Innovation in Digital Preventive Health Solutions
    • Rising Health Insurance Support for Preventive Services Expands Coverage and Reduces Out-of-Pocket Burden
    • Emergence of Digital Biomarkers and Continuous Glucose Monitoring Systems Sustains Innovation in Preventive Health Monitoring
    • Challenges in Data Privacy and Regulatory Compliance Create Demand for Secure, HIPAA-Compliant Preventive Tech Platforms
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Preventive Healthcare Technologies and Services Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Preventive Healthcare Technologies and Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Preventive Healthcare Technologies and Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Early Detection & Screening Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Early Detection & Screening Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Early Detection & Screening Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Chronic Disease Management Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Chronic Disease Management Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Chronic Disease Management Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: USA 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Canada 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: Japan 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • CHINA
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: China 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Preventive Healthcare Technologies and Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Preventive Healthcare Technologies and Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Europe 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: France 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Germany 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Italy 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: UK 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 47: Spain Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Spain Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Spain 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 50: Russia Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Russia Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Russia 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Rest of Europe Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Rest of Europe 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Preventive Healthcare Technologies and Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Preventive Healthcare Technologies and Services by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Asia-Pacific 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 62: Australia Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Australia Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Australia 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • INDIA
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 65: India Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: India Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: India 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 68: South Korea Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: South Korea Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: South Korea 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 71: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Rest of Asia-Pacific Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Rest of Asia-Pacific 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Preventive Healthcare Technologies and Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Preventive Healthcare Technologies and Services by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Latin America 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 80: Argentina Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Argentina Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Argentina 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 83: Brazil Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Brazil Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Brazil 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 86: Mexico Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Mexico Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Mexico 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 89: Rest of Latin America Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Latin America Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Latin America 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Preventive Healthcare Technologies and Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Preventive Healthcare Technologies and Services by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Middle East 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 98: Iran Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Iran Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Iran 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 101: Israel Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Israel Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Israel 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 104: Saudi Arabia Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Saudi Arabia Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Saudi Arabia 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 107: UAE Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UAE Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UAE 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 110: Rest of Middle East Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Middle East Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of Middle East 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • AFRICA
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 113: Africa Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Africa Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Africa 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030

IV. COMPETITION